Literature DB >> 29888209

Successful Hepatic Arterial Infusion of Chemotherapy in a Patient with Advanced Hepatocellular Carcinoma and Impending Liver Failure.

Tsung-Hao Liu1,2, Chih-Hung Hsu2,3, Yu-Yun Shao2,3,4.   

Abstract

Entities:  

Year:  2018        PMID： 29888209      PMCID： PMC5985408          DOI： 10.1159/000486763

Source DB:  PubMed          Journal:  Liver Cancer        ISSN： 1664-5553            Impact factor:   11.740


× No keyword cloud information.
  7 in total

1.  Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma according to Child-Pugh classification.

Authors:  Daisuke Miyaki; Hiroshi Aikata; Yohji Honda; Noriaki Naeshiro; Takashi Nakahara; Mio Tanaka; Yuko Nagaoki; Tomokazu Kawaoka; Shintaro Takaki; Koji Waki; Akira Hiramatsu; Shoichi Takahashi; Masaki Ishikawa; Hideaki Kakizawa; Kazuo Awai; Kazuaki Chayama
Journal:  J Gastroenterol Hepatol       Date:  2012-12       Impact factor: 4.029

2.  Hepatocellular carcinoma in Child-Pugh C cirrhosis: prognostic factors and survival benefit of nontransplant treatments.

Authors:  Masatoshi Kudo; Yukio Osaki; Takashi Matsunaga; Hiroshi Kasugai; Hiroko Oka; Toshihito Seki
Journal:  Dig Dis       Date:  2013-11-21       Impact factor: 2.404

3.  Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial.

Authors:  Anthony B El-Khoueiry; Bruno Sangro; Thomas Yau; Todd S Crocenzi; Masatoshi Kudo; Chiun Hsu; Tae-You Kim; Su-Pin Choo; Jörg Trojan; Theodore H Welling; Tim Meyer; Yoon-Koo Kang; Winnie Yeo; Akhil Chopra; Jeffrey Anderson; Christine Dela Cruz; Lixin Lang; Jaclyn Neely; Hao Tang; Homa B Dastani; Ignacio Melero
Journal:  Lancet       Date:  2017-04-20       Impact factor: 79.321

4.  A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy.

Authors:  Yu-Yun Shao; Po-Chin Liang; Yao-Ming Wu; Chun-Chieh Huang; Kai-Wen Huang; Jason C Cheng; Chih-Hung Hsu; Chiun Hsu; Ann-Lii Cheng; Zhong-Zhe Lin
Journal:  Liver Int       Date:  2013-05-28       Impact factor: 5.828

5.  Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study.

Authors:  Jorge A Marrero; Masatoshi Kudo; Alan P Venook; Sheng-Long Ye; Jean-Pierre Bronowicki; Xiao-Ping Chen; Lucy Dagher; Junji Furuse; Jean-Francois H Geschwind; Laura Ladrón de Guevara; Christos Papandreou; Tadatoshi Takayama; Arun J Sanyal; Seung Kew Yoon; Keiko Nakajima; Robert Lehr; Stephanie Heldner; Riccardo Lencioni
Journal:  J Hepatol       Date:  2016-07-25       Impact factor: 25.083

6.  Sorafenib versus Hepatic Arterial Infusion Chemotherapy as Initial Treatment for Hepatocellular Carcinoma with Advanced Portal Vein Tumor Thrombosis.

Authors:  Michihisa Moriguchi; Takeshi Aramaki; Hideyuki Nishiofuku; Rui Sato; Koiku Asakura; Kanji Yamaguchi; Toshihiro Tanaka; Masahiro Endo; Yoshito Itoh
Journal:  Liver Cancer       Date:  2017-08-29       Impact factor: 11.740

7.  Effect of hepatic arterial infusion chemotherapy of 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma in the Nationwide Survey of Primary Liver Cancer in Japan.

Authors:  K Nouso; K Miyahara; D Uchida; K Kuwaki; N Izumi; M Omata; T Ichida; M Kudo; Y Ku; N Kokudo; M Sakamoto; O Nakashima; T Takayama; O Matsui; Y Matsuyama; K Yamamoto
Journal:  Br J Cancer       Date:  2013-09-05       Impact factor: 7.640
  7 in total
  1 in total

Review 1.  Revisiting Hepatic Artery Infusion Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma.

Authors:  Ching-Tso Chen; Tsung-Hao Liu; Yu-Yun Shao; Kao-Lang Liu; Po-Chin Liang; Zhong-Zhe Lin
Journal:  Int J Mol Sci       Date:  2021-11-28       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.